Literature DB >> 20567248

Cardiovascular risk in the peritoneal dialysis patient.

Raymond T Krediet1, Olga Balafa.   

Abstract

Cardiovascular death is the most frequent cause of death in patients on peritoneal dialysis. Risk factors for cardiovascular death in these patients include those that affect the general population as well as those related to end-stage renal disease (ESRD) and those that are specific to peritoneal dialysis. The development of overhydration after loss of residual renal function is probably the most important cardiovascular risk factor specific to peritoneal dialysis. The high glucose load associated with peritoneal dialysis may lead to insulin resistance and to the development of an atherogenic lipid profile. The presence of glucose degradation products in conventional dialysis solutions, which leads to the local formation of advanced glycation end products, is also specific to peritoneal dialysis. Other risk factors that are not specific to peritoneal dialysis but are related to ESRD include calcifications and protein-energy wasting. When present together with inflammation and atherosclerosis, protein-energy wasting is associated with a marked increase in the risk of cardiovascular death. Obesity is not associated with increased cardiovascular risk in patients on any form of dialysis. Left ventricular hypertrophy and increased arterial stiffness are the most important risk factors for cardiovascular events in the general population.

Entities:  

Mesh:

Year:  2010        PMID: 20567248     DOI: 10.1038/nrneph.2010.68

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  150 in total

1.  Acute effects of peritoneal dialysis on hemodynamics.

Authors:  D Boon; W J Bos; G A van Montfrans; R T Krediet
Journal:  Perit Dial Int       Date:  2001 Mar-Apr       Impact factor: 1.756

2.  B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial.

Authors:  Judith Heinz; Siegfried Kropf; Ute Domröse; Sabine Westphal; Katrin Borucki; Claus Luley; Klaus H Neumann; Jutta Dierkes
Journal:  Circulation       Date:  2010-03-15       Impact factor: 29.690

3.  Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.

Authors:  Francesca Mallamaci; Giovanni Tripepi; Sebastiano Cutrupi; Lorenzo S Malatino; Carmine Zoccali
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

4.  Serial monitoring of nutritional status in Chinese peritoneal dialysis patients by Subjective Global Assessment and comprehensive Malnutrition Inflammation Score.

Authors:  Timothy Hua-Tse Cheng; Debby Hiu-Ha Lam; Steven Kong-Ling Ting; Claudia Lai-Yin Wong; Bonnie Ching-Ha Kwan; Kai-Ming Chow; Man-Ching Law; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Nephrology (Carlton)       Date:  2009-04       Impact factor: 2.506

5.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

Authors:  A S Levey; J A Beto; B E Coronado; G Eknoyan; R N Foley; B L Kasiske; M J Klag; L U Mailloux; C L Manske; K B Meyer; P S Parfrey; M A Pfeffer; N K Wenger; P W Wilson; J T Wright
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

6.  Continuous ambulatory peritoneal dialysis (CAPD) in patients with diabetic nephropathy.

Authors:  F A Kemperman; R van Leusen; F J van Liebergen; J Oosting; E W Boeschoten; D G Struijk; R T Krediet; L Arisz
Journal:  Neth J Med       Date:  1991-06       Impact factor: 1.422

7.  Blood pressure control and left ventricular hypertrophy in long-term CAPD and hemodialysis patients: a cross-sectional study.

Authors:  Ali Ihsan Günal; Erdogan Ilkay; Ercan Kirciman; Ilgin Karaca; Ayhan Dogukan; Huseyin Celiker
Journal:  Perit Dial Int       Date:  2003 Nov-Dec       Impact factor: 1.756

8.  UK Renal Registry 11th Annual Report (December 2008): Chapter 11 Blood pressure profile of prevalent patients receiving dialysis in the UK in 2007: national and centre-specific analyses.

Authors:  Janice Harper; Johann Nicholas; Daniel Ford; Anna Casula; Andrew J Williams
Journal:  Nephron Clin Pract       Date:  2009-03-26

9.  Blood pressure and mortality risk on peritoneal dialysis.

Authors:  Udaya P Udayaraj; Retha Steenkamp; Fergus J Caskey; Chris Rogers; Dorothea Nitsch; David Ansell; Charles R V Tomson
Journal:  Am J Kidney Dis       Date:  2008-11-22       Impact factor: 8.860

10.  Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy.

Authors:  Peter Stenvinkel; Ulf Diczfalusy; Bengt Lindholm; Olof Heimbürger
Journal:  Nephrol Dial Transplant       Date:  2004-04       Impact factor: 5.992

View more
  54 in total

Review 1.  Lipid abnormalities in kidney disease and management strategies.

Authors:  Vishwam Pandya; Akhilesh Rao; Kunal Chaudhary
Journal:  World J Nephrol       Date:  2015-02-06

Review 2.  Should peritoneal resting be advised in ultrafiltration failure associated with a fast peritoneal solute transport status?

Authors:  Raymond T Krediet
Journal:  Perit Dial Int       Date:  2014 Nov-Dec       Impact factor: 1.756

3.  Biomarkers Associated with Vascular Calcification in Peritoneal Dialysis.

Authors:  Juan C Ramirez-Sandoval; Ivan Casanova; Alejandro Villar; F Enrique Gomez; Cristino Cruz; Ricardo Correa-Rotter
Journal:  Perit Dial Int       Date:  2015-08-20       Impact factor: 1.756

4.  Volume-Based Peritoneal Dialysis Prescription Guide to Achieve Adequacy Targets.

Authors:  Alp Akonur; Catherine A Firanek; Mary E Gellens; Audrey M Hutchcraft; Pranay Kathuria; James A Sloand
Journal:  Perit Dial Int       Date:  2015-08-20       Impact factor: 1.756

Review 5.  Association of Body Mass Index With Mortality in Peritoneal Dialysis Patients: A Systematic Review and Meta-Analysis.

Authors:  Seyed-Foad Ahmadi; Golara Zahmatkesh; Elani Streja; Rajnish Mehrotra; Connie M Rhee; Csaba P Kovesdy; Daniel L Gillen; Emad Ahmadi; Gregg C Fonarow; Kamyar Kalantar-Zadeh
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

6.  Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.

Authors:  Jenny I Shen; Anjali B Saxena; Maria E Montez-Rath; Lynn Leng; Tara I Chang; Wolfgang C Winkelmayer
Journal:  J Nephrol       Date:  2016-08-02       Impact factor: 3.902

7.  Relationship between CRP polymorphism and cardiovascular events in Chinese peritoneal dialysis patients.

Authors:  Peter Yam-Kau Poon; Cheuk-Chun Szeto; Bonnie Ching-Ha Kwan; Kai-Ming Chow; Philip Kam-Tao Li
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 8.237

8.  Serum apolipoprotein B is inversely associated with eccentric left ventricular hypertrophy in peritoneal dialysis patients.

Authors:  Min Ye; Yanqiu Liu; Haoyu Wang; Na Tian; Wei Li; Wei He; Hong Lin; Rui Fan; Cuiling Li; Donghong Liu; Fengjuan Yao
Journal:  Int Urol Nephrol       Date:  2017-11-10       Impact factor: 2.370

9.  Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.

Authors:  Alp Akonur; Steven Guest; James A Sloand; John K Leypoldt
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

10.  Long-term effects of spironolactone in peritoneal dialysis patients.

Authors:  Yasuhiko Ito; Masashi Mizuno; Yasuhiro Suzuki; Hirofumi Tamai; Takeyuki Hiramatsu; Hiroshige Ohashi; Isao Ito; Hirotake Kasuga; Masanobu Horie; Shoichi Maruyama; Yukio Yuzawa; Tatsuaki Matsubara; Seiichi Matsuo
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.